Search
 
 
 

WHO WE ARE

Staff, Contact us, About

 
NEWS
Results of COVID-19 treatment trial published
Find out more about the results of the COVID-19 treatment trial in the 6th weekly blog post from Professor Jens Lundgren. 
The post in Danish (24.05.2020) is available here
Full publication of the results is available here.
Vacant positions at CHIP
We are looking for 3 full‐time colleagues to join CHIP, Department of Infectious Diseases at Rigshospitalet. 
- Clinical Research Associate for clinical trial coordination - find out more and apply here
- Project coordinator for infectious disease related research projects - find out more and apply here.
- Data manager/ SQL developer - find out more and apply here.
Applications are open until the 7th of June 2020.
 
Weekly COVID19 update from Professor Jens Lundgren (nr.6)
Find out more about latest developments of COVID-19 pandemic in the 6th weekly blog post from Professor Jens Lundgren. 
The post in Danish (17.05.2020) is available here
 
Fifth weekly update about COVID19 (in Danish)
Latest blog from Prof. Jens Lundgren is focusing on health data analysis and use of medical artificial intelligence (#mAI) as a tool to guide the community and hospitals through the next stages of the COVID-19 pandemic.
Read the update in Danish (from 10.05.2020) here.
 
ACTT trial shows Remdesivir accelerates recovery from advanced COVID-19
The preliminary results of the first randomised study show that people infected with the SARS-CoV-2 coronavirus recover 31% faster if they receive Remdesivir. 
The Adaptive COVID-19 Treatment Trial (ACTT) is coordinated by INSIGHT research network. In Denmark, the study has received support from the Ministry of Higher Education and Science.
More information available in press releases from Rigshospitalet and National Institutes of Health (NIH) and video with NIAID Director Dr Anthony Fauci providing an update on the Remdesivir drug.
 
Latest weekly update from Professor Jens Lundgren
Find out more about the first results of the search for the treatment of COVID-19 in the 4th weekly blog post from Professor Jens Lundgren. 
The post in Danish (03.05.2020) is available here
 
New update about latest situation concerning COVID-19 (in Danish)
Third weekly update by Professor Jens Lundgren touches upon the impact of effective international collaboration in search for effective treatments of COVID19. 
Find the full update in Danish (from 26.04.2020) here.
 
Outcomes of the HepHIV 2019 conference have been published

A short communication presenting outcomes of the HepHIV 2019 Bucharest Conference has been published in HIV Medicine for early view.The biennial HepHIV conference hosted by EuroTEST and in 2019 in collaboration with the INTEGRATE JA, aimed to create multi-stakeholder dialogue to discuss innovative initiatives and best practices of optimal testing and earlier care for HIV, viral hepatitis, STIs and TB from different settings across Europe, including progress and challenges in the integration of services.
Read the full article here.
 

A second weekly update about key issues concerning COVID19 (in Danish)
Another update by Professor Jens Lundgren considers global challenges and research perspectives in tackling SARS-Cov-2 pandemic and potential treatment strategies of COVID19. 
Find the full update in Danish (from 18.04.2020) here.
 
A short update about COVID19 initiatives at CHIP (in Danish)
A recent update by Professor Jens Lundgren highlights the new COVID19 initiatives at CHIP in the light of the latest local and global situation. 
The initiatives include ACCT (Adaptive COVID-19 Treatment Trial) clinical trial within the INSIGHT network and new collaboration CATCH (Corona Application Tool for Collaborating Hospitals)supported by the Novo Nordisk Foundation.
Find the full update in Danish (from 13.04.2020) here.

 
Projects and Collaborations